Munafa Stock Market Course + Intraday & FNO calls 
DRREDDY NEWS why is Dr. Reddy's Laboratories Limited price falling or rising
DRREDDY NEWS reasons for why stock price of Dr. Reddy's Laboratories Limited is falling or rising
DRREDDY Dr Reddy is falling or rising technical reasons
Technical analysis forecast of Dr Reddy Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Dr Reddy DRREDDY at this time. Stock is rising and might rise more.
It appears as if Dr Reddy DRREDDY gave a large move recently.
Stock of Dr Reddy (DRREDDY) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Dr Reddy is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 1287.3 as stoploss in an intra day sell trade for a target of 1255.62. However, stock will show a bullish move above 1287.3.
DRREDDY Dr Reddy is falling or rising NEWS fundamental reasons
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India". - NEWS as on 2026-02-19
Dr Reddy's readies day-1 launch of semaglutide generic Dr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and injectable formats at competitive prices. This move aims to increase access to the popular weight-loss and diabetes mol - NEWS as on 2026-02-19 indiatimes.com
Company Announcement - NEWS as on 2026-02-18
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories closes at 1269.4 - NEWS as on 2026-02-18 indiatimes.com
Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasible Indian drugmaker Dr Reddy's Laboratories is set to launch a generic version of the popular weight-loss drug Wegovy. The company aims to offer it at a price up to 60% lower than the original. This move comes as the patent for semaglutide, the active ingredi - NEWS as on 2026-02-17 indiatimes.com
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'. - NEWS as on 2026-02-17
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-02-13
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-02-12
Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History - NEWS as on 2026-02-11 indiatimes.com
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Sushrut Kulkarni as Other of the company w.e.f. May 08, 2026. - NEWS as on 2026-02-10
Sun Pharma, Dr Reddy's & Lupin call for big push in drug innovation Top Indian pharmaceutical leaders are urging a significant boost in research and development. They believe this focus on innovation is crucial for India to become a global biopharma manufacturing hub. Leaders from Sun Pharma, Cipla, Dr Reddy's Laboratories - NEWS as on 2026-02-09 indiatimes.com
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript - NEWS as on 2026-01-28
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed - NEWS as on 2026-01-27
Company Announcement Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Dr. Reddy s announces the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent o - NEWS as on 2026-01-16
More announcements and NEWS
DRREDDY Dr. Reddy's Laboratories Limited current price & indicator signals
Recent prices of DRREDDY Dr. Reddy's Laboratories Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 20 Fri Feb 2026 | 1280.40 | 1275.00 to 1292.40 | -0.15% | 1.64 times |
| 19 Thu Feb 2026 | 1282.30 | 1276.50 to 1295.70 | 0.16% | 1.25 times |
| 18 Wed Feb 2026 | 1280.30 | 1276.60 to 1291.50 | -0.35% | 0.64 times |
| 17 Tue Feb 2026 | 1284.80 | 1258.20 to 1286.80 | 1.21% | 0.64 times |
| 16 Mon Feb 2026 | 1269.40 | 1257.10 to 1275.20 | 0.1% | 0.44 times |
| 13 Fri Feb 2026 | 1268.10 | 1263.60 to 1279.30 | -0.53% | 0.78 times |
| 12 Thu Feb 2026 | 1274.90 | 1261.50 to 1277.60 | 0.36% | 0.92 times |
| 11 Wed Feb 2026 | 1270.30 | 1253.20 to 1273.50 | 1.14% | 0.8 times |
| 10 Tue Feb 2026 | 1256.00 | 1253.00 to 1283.50 | -1.53% | 1.32 times |
| 09 Mon Feb 2026 | 1275.50 | 1243.50 to 1278.80 | 2.76% | 1.97 times |
| 06 Fri Feb 2026 | 1241.20 | 1225.00 to 1248.90 | -0.3% | 1.24 times |
| 05 Thu Feb 2026 | 1244.90 | 1237.00 to 1253.60 | 0.38% | 0.89 times |
Videos related to: DRREDDY NEWS why is Dr. Reddy's Laboratories Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
